ABSTRACT This study investigated the potential of pinon shell polysaccharide (PSP) to enhance immunity against H9N2 subtype avian influenza virus (H9N2 AIV) in chickens. The effect of PSP treatment and H9N2 virus infection after PSP pretreatment were investigated by [3-(4, 5-dimethylthiazol-2-yl)-2, 3-diphenyl tetrazolium bromide] assay and analysis of major histocompatibility complex and cytokine mRNA expression. The in vivo effects on lymphocytes and serum antibody titers were also investigated. The IL-6 expression and antibody titers were enhanced in the first week after PSP treatment. These data indicate that prophylactic PSP administration reduces H9N2 AIV replication and promotes early humoral immune responses in young birds.
INTRODUCTION
Avian influenza causes an acute and highly contagious respiratory disease with potentially fatal outcomes in animals (Haga and Horimoto, 2010) . The H9N2 subtype influenza virus belongs to the lowly pathogenic avian influenza virus (AIV) group, which is considered to be common cause of disease epidemics (Kwon et al., 2008; Lee et al., 2011) . Recent compelling evidence has demonstrated that H9N2 virus not only leads to reduced production performance especially in egg production, but also is associated with bacteria such as Staphylococcus aureus and Haemophilus paragallinarum or attenuated vaccine strains that exacerbate the disease (Kwon et al., 2008; Okamatsu et al., 2008) .
The H9N2 virus infection presents a significant challenge to host survival, although vaccination has revealed effective antiviral defense and is implicated as promising control measure . However, individuals are still infected when the viruses are disseminated throughout the environment. Development of novel immune adjuvant is required to enhance the capacity of the vaccine to form a fast host immune response to protect individuals against viruses.
Polysaccharides form the basis of cell surface signal identification, antigen-antibody reactions, and intercellular information transmission and perception (Wei et al., 2011) . Pinon shell polysaccharide (PSP) is an important biomacromolecule exhibiting a complicated structure and species specificity. Pinon shell polysaccharide has previously been shown to enhance antiviral activity against influenza viruses, human immunodeficiency virus, herpes simplex virus , and rotavirus and enterovirus infections in vitro (Mukoyama et al., 1991) . Furthermore, PSP exhibits many functions, including stimulation of morphological change in macrophages, acceleration of DNA synthesis in splenic cells, and stimulation of polymorphonuclear cells (Baba et al., 1997) . However, current research into the pharmacological efficacy of PSP has shown no discernible progress.
In this study, the effects of PSP on the propagation of H9N2 AIV and expression of IL-2, IL-4, IL-6, and IL-10 mRNA were investigated in chicken embryo fibroblasts (CEF). The study was extended to investigate the antiviral potential of PSP to inhibit H9N2 AIV. Changes in peripheral blood lymphocytes and antibody titers were analyzed in chickens before and after immunization to evaluate the immunoregulatory potential of PSP in vivo. lantoic fluids were harvested after 48 h and concentrated with a 100 K tangential flow filtration capsule (Pall Life Sciences, Ann Arbor, MI) by centrifugation at 60,000 × g for 1 h. The suspension was loaded onto a 30 to 60% (wt/wt) sucrose gradient and subjected to centrifugation at 39,750 × g at 4°C with SW-40 Ti rotor (Beckman Instruments, Palo Alto, CA) for 3 h using the slowest acceleration and braking rates. The viral pellets were washed and 60,000 × g centrifuged at 4°C for 1 h. Subsequently, pellets were redissolved in 1 mL of PBS, filtered with a 0.22-μm Millipore filter (Millipore Corp., Bedford, MA) , and stored at −70°C (Suomalainen et al., 1992; Liu et al., 2011; Rao et al., 2011; Spitteler et al., 2011) .
The CEF cultures were prepared from 9-to 11-dold chicken embryos according to the method of standard procedures. Dulbecco's modified Eagle media (Gibco-Invitrogen, Carlsbad, CA) supplemented with 10% (vol/vol) BSA (Gibco-Invitrogen) was used as the growth medium. Embryo tissue was cut into pieces and diluted to 1 × 10 6 cells/mL. After filtration, cells were cultivated in a 5% (vol/vol) CO 2 incubator at 37°C for 48 h (Maas et al., 2006; Yang et al., 2010; Park et al., 2011) .
Determination of Optimal PSP Concentration
Sextuplicate CEF confluent monolayers were overlaid with serial doubling dilutions of PSP in culture mediums (321.25 to 4.833 μg/mL) in 96-well culture plates, and cultured at 37°C in a humidified 5% CO 2 incubator for 8 h. The effect of PSP on CEF viability was measured by MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 3-diphenyl tetrazolium bromide] assay. After removing the media, 20 μL of MTT (Amresco, Solon, OH; 5 μg/ mL) was added and incubated at 37°C in a humid atmosphere of 5% (vol/vol) for 4 h. Dimethyl sulphoxide (Sigma, Kent, UK) was then added, and the plates were incubated at 37°C for 5 min to dissolve formazan crystals. Absorbance was measured at 570 nm using a microtitrator ELISA reader (Molecular Devices Emax, Sunnyvale, CA).
Antiviral Assays
Antiviral activity was evaluated as previously as reported by Huang et al. (2008) . The PSP was added to CEF before the viruses [50× tissue culture infective dose (TCID) 50 H9N2] in the PSP pretreatment group.
Bird Experiment
The SPF White leghorn avian broilers (150) were purchased from Guangdong Dahuanong Animal Health Products Co. Ltd. Broilers (aged 5 d) were divided into 4 groups and maintained in 4 separate positive pressure isolators. Experimental groups contained 3 sample groups (30 chicks per group) and 1 control group (60 chicks, including negative and vaccine controls).
The PSP was hypodermically injected (5, 10, and 20 mg/kg) to the experimental groups of chicks (age 7 d), once a day for 5 successive days. The chickens in control group were treated with PBS. At 12 d posthatching, 6 chickens per group were euthanized by cervical dislocation and blood (5 mL per chick) was collected immediately. Peripheral blood lymphocytes were isolated for flow cytometry. All immune organs were weighted for statistical analyses and immediately stored at −70°C. Simultaneously, 9 chicks per group were challenged respectively with 10 7.5 embryo infective dose (EID) 50 /0.2 mL of H9N2 AIV.
Additionally, 15 chicks per group (with the exception of the negative control group) were immunized subcutaneously with an inactivated H9N2 AIV oil-emulsion vaccine (Guangdong Dahuanong Animal Health Products Co. Ltd.) at 13 and 20 d posthatching. The negative control was treated with PBS. Antibody titers were measured at 7 and 14 d postimmunization.
The experimental procedures performed on birds 12 d posthatching were repeated at 26 d posthatching.
Three-Color Flow Cytometry
Blood samples were collected into sodium heparin and mixed with an equal volume of Hanks' balanced salt solution (pH 7.2 to 7.4) for flow cytometric analysis. An aliquot was layered over 5 mL of lymphocyte separation medium and centrifuged at 2,400 × g for 20 min at 4°C in a swinging-bucket rotor. Peripheral blood lymphocyte were recovered from the lymphocyte separation medium-Hanks' balanced salt solution interface. The peripheral blood lymphocytes were collected and washed 3 times with PBS. A total of 2 × 10 6 lymphocytes in RPMI 1640 medium containing 10% (vol/vol) BSA were incubated with 20 μL of anti-chicken CD3-PE (SouthernBiotech, Birmingham, AL), CD4-FITC (SouthernBiotech), and CD8-CY5 (SouthernBiotech) in darkness for 20 min. Cell suspensions were washed with 500 μL of PBS and centrifugation at 1,500 × g for 10 min at 4°C. The supernatant was removed and cells resuspended in 500 μL of PBS (Fair et al., 2008) . Cells were analyzed using a BD FACSAria flow cytometer (version 6.1, BD Biosciences, San Jose, CA).
Real-Time PCR
Total RNA was extracted from CEF using Trizol reagent (TaKaRa Biotechnology, Dalian, China) according to the protocol provided by the manufacturer. The RNA concentrations were measured spectrophotometerically (A260/280, 1.8 to 2.0). Isolated RNA was digested with recombinant DNase I (TaKaRa Biotechnology, Dalian, China) at 37°C for 30 min. The cDNA was synthesized by reverse transcription (RT) using a Rever Tra Ace QPCR RT kit (Toyobo, Osaka, Japan) in a total volume of 20-μL SYBR Green Real-time PCR Master Mix (Roche, Mortlake, Australia). Quantitative RT-PCR was conducted with the Stratagene Mx3005P QPCR system (Stratagene, La Jolla, CA). After 94°C initial denaturation at 10 min, 40 cycles of amplification were carried out, consisting of denaturation at 95°C for 10 s and primer annealing at 58°C for 30 s. All reactions were performed in triplicate. Relative expression (fold change) was calculated by the 2 -ΔΔCt method, and glyceraldehyde-3-phosphate-dehydrogenase was used as the endogenous reference gene to normalize the expression level of target genes. The primers used in real-time PCR assays are listed in Table 1 .
Statistical Analysis
All data are shown as the mean ± SEM. Comparisons between 2 groups were analyzed using unpaired Student's t-tests, and among multiple groups by post hoc ANOVA with Tukey's multiple comparison test using SPSS 17.0 software (SPSS, Chicago, IL). Differences between means were considered statistically significant at probability values (P-values) less than 0.05. All experiments were repeated at least 3 times.
RESULTS

Optimal PSP Concentration and Antiviral Assays
Determination of the optimal PSP concentration and detailed results of antiviral assays are shown in Table  2 . The optimal concentration of PSP for stimulation of CEF proliferation was determined to be 321.25 μg/ mL. The CEF proliferation was enhanced in the presence of PSP at all concentration tested compared with the control cells, with increased proliferation at PSP concentration over the range from 4.833 to 321.25 μg/ mL. These data indicated that CEF proliferation could be enhanced by PSP over 4.833 μg/mL. Similar results were obtained following pretreatment of CEF with PSP. The A570 values produced in the PSP pretreatment group were approximately the same as those in the cell control group, with the highest values obtained in the presence of 321.25 μg/mL of PSP pretreatment before virus infection. To compare the intercluster discrepancy of each group, 10 gradients were used for administering A570 values of each group with 6 repetitions.
Replication of H9N2 AIV on CEF
The H9N2 AIV was minimally expressed in PSP groups, and concentrations of 321.25 μg/mL and 4.833 μg/mL were effective in controlling established viral infection, with greater efficacy observed in the presence of 321.25 μg/mL PSP compared with 4.833 μg/ mL (Figure 1 ).
Major Histocompatibility Complex and Cytokine Expression in CEF
The dynamic changes of cytokines expression in CEF are showed in Figures 2 and 3 . No significant differences were observed in the relative expression of major histocompatibility complex (MHC) and cytokines such as IL-2, IL-4, IL-10, and interferon (IFN)-γ. However, IL-6 expression was detected at extremely high levels following PSP treatment. Furthermore, the relative expression of MHC and IL-2, IL-6, IL-10 was enhanced in response to H9N2 virus infection following PSP treatment.
Differential Induction of CD3+, CD4+, and CD8+ T Cells
The proportions of lymphocytes expressing CD3+, CD4+, and CD8+ were detected. No significant difference in the percentages of CD3+ lymphocytes in peripheral blood was detected following PSP administration or H9N2 virus infection following PSP pretreatment compared with the control. Although no significant differences were detected in the percentages of CD4+ lymphocytes compared with the control, lower levels of CD8 cytotoxic cells treated with PSP were observed following with PSP treatment compared with the control before PSP treatment, but expanded rapidly after vaccination. Furthermore, CD8+ ratios were 
Antibody Levels
Antibody titers in PSP treated groups increased significantly more quickly than the control groups in the first week after H9N2 challenge (Figure 4) . In postimmunization, the highest antibody titers were observed in the group treated with 5 mg/kg of PSP following administration of inactivated vaccine ( Figure 5 ). No statistically significant differences in antibody titer were detected between the PSP-treated groups and the control group at 14 d postvaccine administration.
DISCUSSION
The cellular immune response forms a critical part of the host defense system against infection by accelerating the clearance of pathogens and secreting numerous cytokines that mediate regulation of the immune response (Zhang et al., 2010) . Investigation of the effect of PSP on CEF proliferation in preliminary MTT assays showed a reduction in proliferation between 2,500 and 321.25 μg/mL. Significantly higher CEF proliferation was observed in the presence of 321.25 μg/mL of PSP compared with the control groups. Based on these observations and the practicability of PSP administration, all subsequent in vitro experiments were carried out using 321.25 and 4.833 μg/mL. In virus infection assays, CEF cells treated with PSP at 321.25 μg/mL exhibited greater proliferative capacity than the cell in the virus control group, thus indicating the protective potential of PSP against the H9N2 AIV. Furthermore, real-time PCR analysis showed that the propagation of H9N2 AIV in CEF was reduced after PSP pretreatment, and virus propagation was minimal in the presence of 321.25 μg/mL of PSP. These data were consistent with the result obtained in antiviral assay and Antigens are captured by professional antigen-presenting cells (APC) and then the antigens are broken down and presented in association with the MHC molecules of the APC. The T cells recognize the microbial antigens expressed on the APC, and the T cells are activated and induced the specific immunity (Delves and Roitt, 2000; Wang, 2001 ). In the study, expression of MHC molecules and cytokines such as IL-2, IL-4, IL-10, and IFN-γ were reduced in response to H9N2 virus infection following PSP treatment. Our data showed no significant differences in total lymphocyte and CD4+ T cells numbers following PSP pretreatment compared with the control group. These data are consistent with previous reports showing no significant changes in the rations of splenic CD4+ T cells following PSP treatment (Baba et al., 1997) and indicate that PSP does not cause significant changes in peripheral blood leukocytes and lymphocyte subsets in young, healthy birds. Following influenza virus infection, significantly higher levels of MHC class I expression were detected in the PSP-treated group compared with the PSP-untreated group. Similarly, the percentages of CD4+ and CD8+ T cells were increased with concomitant upregulation of IL-2, IL-4, and IL-10 expressions. These observations suggest that PSP boost both T and B cells. Expression of IL-4 and IL-10 is important in the generation of mammalian Th2 type responses and inhibits Th1 responses (Delves and Roitt, 2000; Hilton et al., 2002) . The Th2 type responses are amplified by these 2 cytokines. Interleukin-4 acts on helper T cells to enhance the production of Th2 cytokines, whereas IL-10 inhibits secretion of a variety of cytokines such as IL-2 and IFN-γ by helper T cells and IL-12 by dendritic cells and macrophages (Nobuo et al., 1996) . Because they are the effector cells of Th2 type response, upregulation of IL-4 and IL-10 indicates active B cell immunity.
Cytokines can be categorized as characteristic of different CD4+ T cells subsets, including Th1 cells and Th2 cells. Interleukin-2 and IFN-γ are secreted by Th1 cells and promote cell-mediated immunity (Guleria et al., 1993) . However, in this study, IFN-γ production was decreased and IL-2 expression was increased in response to H9N2 virus challenge. It can be deduced that macrophage production is involved in the mechanism by which the immunomodulatory effect of PSP occurs. Intriguingly, very high levels of IL-6 were produced both before and after H9N2 virus challenge, suggesting that IL-6 induces long-term protective immunity against a lethal challenge of influenza virus (Lee et al., 1999) . Therefore, this enhancement of IL-6 production indicates that PSP boost humoral immunity against the H9N2 influenza virus.
Some linear antigens, which are not readily degraded in the body and possess an appropriately spaced, highly repeated antigen such as the pneumococcal polysaccharide, may be thymus-independent in their ability to stimulate B cells directly without the need for T cell involvement (Rabson et al., 2005) . Evidence suggests that PSP, as one of these linear antigens, persists for long periods on the surface of specialized macrophages situated at the subcapsular sinus of the lymph nodes and the splenic marginal zone. Serum antibody titers are an indicator of humoral immunity. This study demonstrated significantly higher antibody titers in the PSP-treated groups compared with the control group 1 wk after H9N2 virus challenge and postimmunization with the inactivated vaccine. These data implicate PSP as an antiviral agent and suggest that suitable doses will enhance antibody production and improve humoral immunity. Furthermore, no differences in antibody titers were observed between the PSP immunized and control groups after 2 wk.
This study demonstrated that the use of PSP at the optimum concentration promoted CEF growth and protection against H9N2 virus challenge. The immunoregulatory functions of PSP were shown to be most effective in the inhibition of virus replication, whereas the levels of MHC class II and cytokines of IL-2, IL-4, and IL-10 expression were highest after H9N2 virus challenge. High levels of IL-6 expression were maintained after PSP immunization. Analysis of CD4+ and CD8+ T cells numbers indicated that PSP has the potential to diminish viral damage in chickens. Antibody titers were increased compared with the control following both H9N2 virus challenge and inactive vaccine immunization. In conclusion, our results provide evidence that PSP has a beneficial effect on inhibition of H9N2 virus infection and may be developed as a novel immunopotentiator. 
